This spatially controlled CAR synthesis was confirmed in vivo by generating xenograft mouse models simultaneously bearing WT (CD19+GFP-) and modified (CD19+GFP+) Daudi tumor cells (in separate body sites). Here, CD19 is linked to neoplasm.